Compare equities side by side
Stocks breaking to new annual highs
S&P 500 oversold value screener
Relative strength momentum leaders
Upcoming earnings dates & reports
Filter and sort all 500 stocks
Today's biggest gainers and losers
Visual sector performance
Porvair plc is a UK-based specialty filtration and environmental technology company operating through three divisions: Aerospace & Industrial (filtration for aerospace fuel systems, industrial processes), Laboratory (microplates and filtration for life sciences research), and Metal Melt Quality (filtration systems for aluminum and magnesium casting). The company serves niche markets with engineered products requiring technical expertise, generating approximately 70% of revenue from aerospace and industrial applications with the remainder from laboratory consumables and metal casting filtration.
Porvair generates revenue through engineered-to-order filtration systems with high switching costs due to technical specifications and regulatory approvals (particularly aerospace). Aerospace products benefit from long product lifecycles and recurring aftermarket revenue as filters require periodic replacement. Laboratory consumables provide recurring revenue from research institutions and pharma companies. Metal casting filters are sold per production run, creating volume-based revenue tied to automotive and aerospace manufacturing activity. Gross margins of 35.4% reflect specialized manufacturing and technical service content, with pricing power derived from performance criticality rather than commodity competition.
Commercial aerospace build rates and aftermarket flight hours (drives fuel filter replacement cycles and new aircraft deliveries)
Pharmaceutical R&D spending and biotech funding environment (impacts laboratory consumables demand)
Global automotive and aerospace aluminum casting volumes (determines metal filtration system utilization)
UK pound sterling exchange rate movements (significant non-UK revenue exposure creates FX translation effects)
Aerospace OEM production schedules from Boeing and Airbus (long lead times for fuel system components)
Aerospace industry consolidation among OEMs (Boeing/Airbus duopoly) and Tier 1 suppliers increases customer bargaining power and pricing pressure on component suppliers
Shift toward electric vehicles reduces aluminum engine block casting demand, pressuring Metal Melt Quality division (though aerospace aluminum demand remains strong)
Laboratory automation and integrated lab systems could disrupt standalone microplate and filtration consumables market
Regulatory changes in aerospace certification (EASA, FAA) could increase compliance costs or delay new product introductions
Larger diversified filtration competitors (Pall Corporation/Danaher, Parker Hannifin) have greater R&D resources and can bundle products for aerospace customers
Low-cost Asian manufacturers entering metal casting filtration market with price competition (though quality/performance barriers exist)
Private equity-backed laboratory consumables consolidation creating larger competitors with better distribution scale
Limited financial risk given conservative capital structure (debt/equity 0.16, current ratio 2.54), but small market cap ($300M) limits access to capital markets for transformative M&A
Pension obligations common for UK industrials (not disclosed in provided data) could represent off-balance sheet liability
Working capital intensity in aerospace (long production cycles, inventory requirements) could pressure cash flow if revenue declines sharply
moderate-high - Aerospace exposure provides some defensiveness through aftermarket annuities and long product cycles, but new aircraft production and airline capex are cyclically sensitive. Laboratory products tied to pharmaceutical R&D budgets show moderate cyclicality (pharma spending more stable than industrial capex). Metal casting division is highly cyclical, directly linked to automotive production volumes and industrial manufacturing activity. Overall revenue correlation to industrial production estimated at 0.6-0.7, with 18-24 month lag for aerospace OEM cycles.
Rising rates create moderate headwinds through multiple channels: (1) higher discount rates compress valuation multiples for industrial stocks trading at 12-13x EV/EBITDA, (2) stronger USD from rate differentials pressures non-US revenue translation (estimated 60%+ revenue outside UK), (3) reduced biotech/pharma venture funding in high-rate environment dampens laboratory consumables demand from smaller research firms. However, minimal direct impact from financing costs given low debt/equity of 0.16. Rate sensitivity primarily valuation-driven rather than operational.
Minimal direct credit exposure given strong balance sheet (current ratio 2.54, debt/equity 0.16). However, indirect exposure through customer credit quality: aerospace OEMs and airlines face financing challenges in tight credit conditions, potentially delaying orders or extending payment terms. Pharmaceutical and biotech customers may face reduced access to capital markets for R&D funding. Metal casting customers (automotive suppliers) are credit-sensitive and may reduce inventory/production in credit crunches. Customer concentration risk not disclosed but typical in aerospace supply chain.
value - Stock trades at 2.0x sales and 12.2x EV/EBITDA with 5.3% FCF yield, below historical industrials multiples. Recent 28% one-year decline suggests value opportunity if aerospace recovery materializes. Attracts UK small-cap value investors and specialized industrial investors focused on niche manufacturing. Limited institutional ownership due to small market cap and UK listing. Not a growth story given 0.6% revenue growth, but ROE of 11.2% and cash generation appeal to value-oriented funds seeking quality compounders at reasonable prices.
moderate-high - Small-cap industrial with limited liquidity creates higher volatility than large-cap peers. Beta likely 1.2-1.4 given aerospace exposure and UK small-cap characteristics. Recent 35.6% three-month decline indicates elevated volatility, possibly driven by aerospace industry concerns or company-specific issues. Quarterly earnings can move stock 10-15% given thin float. Currency volatility adds additional risk for USD-based investors.